Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression.
Grassadonia A, Graziano V, Pagotto S, Veronese A, Giuliani C, Marchisio M, Lanuti P, De Tursi M, D'Egidio M, Di Marino P, Brocco D, Vici P, De Lellis L, Cama A, Natoli C, Tinari N. Grassadonia A, et al. Among authors: veronese a. Cell Death Discov. 2021 Apr 22;7(1):86. doi: 10.1038/s41420-021-00469-1. Cell Death Discov. 2021. PMID: 33888686 Free PMC article.
Correction: Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression.
Grassadonia A, Graziano V, Pagotto S, Veronese A, Giuliani C, Marchisio M, Lanuti P, De Tursi M, D'Egidio M, Di Marino P, Brocco D, Vici P, De Lellis L, Cama A, Natoli C, Tinari N. Grassadonia A, et al. Among authors: veronese a. Cell Death Discov. 2021 May 11;7(1):100. doi: 10.1038/s41420-021-00490-4. Cell Death Discov. 2021. PMID: 33976112 Free PMC article. No abstract available.
Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study.
Grassadonia A, Di Marino P, Ficorella C, Cortellini A, Cannita K, Parisi A, Gamucci T, Zoratto F, Vici P, Barba M, Porreca E, Neri M, Veronese A, Natoli C, De Tursi M, Tinari N. Grassadonia A, et al. Among authors: veronese a. J Cancer. 2019 Oct 15;10(24):5926-5934. doi: 10.7150/jca.34550. eCollection 2019. J Cancer. 2019. PMID: 31762802 Free PMC article.
Epigenetics and MicroRNAs in Cancer.
Ramassone A, Pagotto S, Veronese A, Visone R. Ramassone A, et al. Among authors: veronese a. Int J Mol Sci. 2018 Feb 3;19(2):459. doi: 10.3390/ijms19020459. Int J Mol Sci. 2018. PMID: 29401683 Free PMC article. Review.
Hsa-miR-155-5p drives aneuploidy at early stages of cellular transformation.
Pagotto S, Veronese A, Soranno A, Lanuti P, Di Marco M, Russo MV, Ramassone A, Marchisio M, Simeone P, Guanciali-Franchi PE, Palka G, Costantini RM, Croce CM, Visone R. Pagotto S, et al. Among authors: veronese a. Oncotarget. 2018 Feb 7;9(16):13036-13047. doi: 10.18632/oncotarget.24437. eCollection 2018 Feb 27. Oncotarget. 2018. PMID: 29560129 Free PMC article.
Enhanced Expression of miR-181b in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell Response.
Di Marco M, Veschi S, Lanuti P, Ramassone A, Pacillo S, Pagotto S, Pepe F, George-William JN, Curcio C, Marchisio M, Miscia S, Innocenti I, Autore F, Vannata B, Di Gregorio P, Di Gioacchino M, Valentinuzzi S, Iezzi M, Mariani-Costantini R, Larocca LM, Laurenti L, Veronese A, Visone R. Di Marco M, et al. Among authors: veronese a. Cancers (Basel). 2021 Jan 12;13(2):257. doi: 10.3390/cancers13020257. Cancers (Basel). 2021. PMID: 33445508 Free PMC article.
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.
Lupini L, Pepe F, Ferracin M, Braconi C, Callegari E, Pagotto S, Spizzo R, Zagatti B, Lanuti P, Fornari F, Ghasemi R, Mariani-Costantini R, Bolondi L, Gramantieri L, Calin GA, Sabbioni S, Visone R, Veronese A, Negrini M. Lupini L, et al. Among authors: veronese a. Oncotarget. 2016 May 24;7(21):31361-71. doi: 10.18632/oncotarget.8913. Oncotarget. 2016. PMID: 27120784 Free PMC article.
Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib.
Verginelli F, Perconti S, Vespa S, Schiavi F, Prasad SC, Lanuti P, Cama A, Tramontana L, Esposito DL, Guarnieri S, Sheu A, Pantalone MR, Florio R, Morgano A, Rossi C, Bologna G, Marchisio M, D'Argenio A, Taschin E, Visone R, Opocher G, Veronese A, Paties CT, Rajasekhar VK, Söderberg-Nauclér C, Sanna M, Lotti LV, Mariani-Costantini R. Verginelli F, et al. Among authors: veronese a. Acta Neuropathol. 2018 May;135(5):779-798. doi: 10.1007/s00401-017-1799-2. Epub 2018 Jan 5. Acta Neuropathol. 2018. PMID: 29305721 Free PMC article.
137 results